Notice of Intent To Grant an Exclusive License; Adaptive Phage Therapeutics, Inc., 92791-92792 [2016-30590]

Download as PDF Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices accordance with the Magnuson-Stevens Fishery Conservation and Management Act, those issues may not be the subject of formal action during this meeting. Actions of the Working Group will be restricted to those issues specifically identified in the agenda and any issues arising after publication of this notice that require emergency action under Section 305(c) of the Magnuson-Stevens Fishery Conservation and Management Act, provided the public has been notified of the Council’s intent to take action to address the emergency. Dated: December 14, 2016. Tracey L. Thompson, Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2016–30500 Filed 12–19–16; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF COMMERCE Patent and Trademark Office mstockstill on DSK3G9T082PROD with NOTICES Submission for OMB Review; Comment Request; Secrecy and License To Export The United States Patent and Trademark Office (USTPO) will submit to the Office of Management and Budget (OMB) for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35). Agency: United States Patent and Trademark Office, Commerce. Title: Secrecy and License to Export. OMB Control Number: 0651–0034. Form Number(s): None. Type of Request: Revision of a currently approved collection. Number of Respondents: 2,559 per year. Average Hours Per Response: Between 30 minutes (0.5 hours) and 4 hours to gather the necessary information, prepare the materials, and to submit it to the USPTO, depending upon the instrument used and the complexity of the situation. Burden Hours: 1607.5 hours. Cost Burden: $448,267.70. Needs and Uses: This information is required by 35 U.S.C. 181–188 and administered by the USPTO through 37 CFR 5.1–5.22 and 1.17. This collection includes the information needed by the USPTO to review the various types of petitions regarding secrecy orders and to issue or revoke foreign filing licenses. Responses to this information collection is necessary to obtain a permit to disclose, modify or rescind a secrecy order; to obtain general or group permits; to obtain foreign filing licenses, including retroactive foreign filing VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 licenses; or to change the scope of a license. Affected Public: Businesses or other for-profits; not-for-profit institutions. Frequency: On occasion. Respondent’s Obligation: Required to Obtain or Retain Benefits. OMB Desk Officer: Kimberly R. Keravouri, email: Kimberly_R_ Keravouri@omb.eop.gov. Once submitted, the request will be publicly available in electronic format through reginfo.gov. Follow the instructions to view Department of Commerce collections currently under review by OMB. Further information can be obtained by: • Email: InformationCollection@ uspto.gov. Include ‘‘0651–0034 copy request’’ in the subject line of the message. • Mail: Marcie Lovett, Records Management Division Director, Office of the Chief Information Officer, United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313– 1450. Written comments and recommendations for the proposed information collection should be sent on or before January 19, 2017 to Kimberly R. Keravouri, OMB Desk Officer, via email to Kimberly_R_Keravouri@ omb.eop.gov, or by fax to 202–395– 5167, marked to the attention of Kimberly R. Keravouri. Dated: December 13, 2016. Marcie Lovett, Records Management Division Director, OCIO, United States Patent and Trademark Office. [FR Doc. 2016–30506 Filed 12–19–16; 8:45 am] BILLING CODE 3510–16–P capabilities in the western Pacific and conduct military exercises. The decision was based on matters discussed in the Final EIS; inputs from the public, Federal, the Commonwealth of the Northern Mariana Islands, and local units of government, and regulatory agencies; and other relevant factors. The Final EIS was made available to the public on September 26, 2016 through a NOA in the Federal Register (Volume 81, Page 66013) with a post-filing waiting period that ended on October 26, 2016. This ROD documents only the Air Force decision on the proposed actions analyzed in the Final EIS. Authority: This NOA is published pursuant to the regulations (40 CFR Sec. 1506.6) implementing the provisions of the National Environmental Policy Act of 1969 (42 U.S.C. 4321, et seq.) and the Air Force’s Environmental Impact Analysis Process (32 CFR Secs. 989.21(b) and 989.24(b)(7)). FOR FURTHER INFORMATION CONTACT: Mark Petersen, 25 E Street, C–310, JBPHH, HI 96853, (808) 449–1078. Henry Williams, Acting Air Force Federal Register Liaison Officer. [FR Doc. 2016–30488 Filed 12–19–16; 8:45 am] BILLING CODE 5001–10–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant an Exclusive License; Adaptive Phage Therapeutics, Inc. AGENCY: ACTION: DEPARTMENT OF DEFENSE Divert Activities and Exercises, Commonwealth of the Northern Mariana Islands Notice of Availability (NOA) Record of Decision (ROD). ACTION: On December 7, 2016, the United States Air Force signed the ROD for the Divert Activities and Exercises, Commenwealth of the Northern Mariana Islands Final Environmental Impact Statement (EIS). This ROD states the Air Force decision is to implement Alternative 2—Modified Tinian Alternative, and specifically the North Option. The decision means that the Air Force will construct the facilities and infrastructure needed to achieve divert PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 Department of the Navy, DoD. Notice. The Department of the Navy hereby gives notice of its intent to grant Adaptive Phage Therapeutics, Inc. a revocable, nonassignable, exclusive license to practice worldwide the Government owned inventions described in U.S. Provisional Patent Application 62/353,517, filed 22 June 2016 and entitled ‘‘Bacteriophage compositions and methods of selection of components against specific bacteria’’ as well as any issued patent, divisional or continuation from that and related foreign filings in the field of antibiotics and drug-resistant bacteria control. SUMMARY: Department of the Air Force SUMMARY: 92791 Anyone wishing to object to the grant of this license has fifteen (15) days from the date of this notice to file written objections along with supporting evidence, if any, not later than January 4, 2017. DATES: E:\FR\FM\20DEN1.SGM 20DEN1 92792 Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices Written objections are to be filed with Attn: Naval Medical Research Center, Code 1URO/OPBD, 503 Robert Grant Avenue, Silver Spring, MD 20910–7500. FOR FURTHER INFORMATION CONTACT: Dr. T.A. Ponzio, Director, Partnerships & Business Development, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500; todd.a.ponzio.civ@mail.mil; telephone: 240–762–0673. ADDRESSES: Authority: 35 U.S.C. 207, 37 CFR part 404. Dated: December 14, 2016. A.M. Nichols, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2016–30590 Filed 12–19–16; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant an Exclusive License; DBC Medical Innovations, LLC Department of the Navy, DoD. ACTION: Notice. AGENCY: The Department of the Navy hereby gives notice of its intent to grant DBC Medical Innovations, LLC a revocable, nonassignable, exclusive license to practice worldwide the Government owned inventions described in U.S. Patent Application 15/ 090,047, filed 04 April 2016 and entitled ‘‘User Adjustable Prosthetic Ankle That Compensates for Different Heel Heights’’ as well as any issued patent, divisional or continuation from that and related foreign filings in the field of prosthetics. DATES: Anyone wishing to object to the grant of this license has fifteen (15) days from the date of this notice to file written objections along with supporting evidence, if any, not later than January 4, 2017. ADDRESSES: Written objections are to be filed with Attn: Naval Medical Research Center, Code 1URO/OPBD, 503 Robert Grant Avenue, Silver Spring, MD 20910–7500. FOR FURTHER INFORMATION CONTACT: Dr. T.A. Ponzio, Director, Partnerships & Business Development, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500; todd.a.ponzio.civ@mail.mil; telephone: 240–762–0673. mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: Authority: 35 U.S.C. 207, 37 CFR Part 404. VerDate Sep<11>2014 19:36 Dec 19, 2016 Jkt 241001 Dated: December 13, 2016. A.M. Nichols, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2016–30582 Filed 12–19–16; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant an Exclusive License; SpringStar Inc. Department of the Navy, DoD. Notice. AGENCY: ACTION: The Department of the Navy hereby gives notice of its intent to grant SpringStar Inc. a revocable, nonassignable, exclusive license to practice worldwide the Government owned inventions described in U.S. Patent Application 14/870,170 filed April 22, 2015 and entitled ‘‘Modular insect trap,’’ as well as any issued patent, divisional or continuation from that and related foreign filings in the field of insect control. DATES: Anyone wishing to object to the grant of this license has fifteen (15) days from the date of this notice to file written objections along with supporting evidence, if any, not later than January 4, 2017. ADDRESSES: Written objections are to be filed with Attn: Naval Medical Research Center, Code 1URO/OPBD, 503 Robert Grant Avenue, Silver Spring, MD 20910–7500. FOR FURTHER INFORMATION CONTACT: Dr. T.A. Ponzio, Director, Partnerships & Business Development, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500; todd.a.ponzio.civ@mail.mil; telephone: 240–762–0673. SUMMARY: Authority: 35 U.S.C. 207, 37 CFR part 404. Dated: December 13, 2016. A.M. Nichols, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2016–30591 Filed 12–19–16; 8:45 am] BILLING CODE 3810–FF–P Notice of Intent To Grant Exclusive Patent License; Solar Tech, Inc. Department of the Navy, DoD. ACTION: Notice. AGENCY: Fmt 4703 Dated: December 12, 2016. A.N. Michols, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 2016–30586 Filed 12–19–16; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE Notice of Intent To Grant an Exclusive License; Rotunda Scientific Technologies, LLC Department of the Navy Frm 00023 Authority: 35 U.S.C. 207, 37 CFR part 404. Department of the Navy DEPARTMENT OF DEFENSE PO 00000 The Department of the Navy hereby gives notice of its intent to grant to Solar Tech, Inc., a revocable, nonassignable, exclusive license to practice in the field of use of flexible solar cells for renewable energy generation for application on a building or structure in the United States, the Government-owned inventions described in U.S. Patent Application No. 14/051,134: Spray Deposition Method for Inorganic Nanocrystal Solar Cells, Navy Case No. 101,963.//U.S. Patent Application No. 14/051,226: Inorganic Nanocrystal Solar Cells, Navy Case No. 101,963.//U.S. Patent Application No. 14/256,263: Top to Bottom Solution Deposition of Inorganic Solar Modules, Navy Case No. 102,634.//U.S. Patent Application No. 15/266,878: Top to Bottom Solution Deposition of Inorganic Solar Modules, Navy Case No. 102,634 and any continuations, divisionals or re-issues thereof. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than January 4, 2017. ADDRESSES: Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue SW., Washington, DC 20375– 5320. FOR FURTHER INFORMATION CONTACT: Charles Steenbuck, Acting Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue SW., Washington, DC 20375–5320, telephone 202–767–3083. Due to U.S. Postal delays, please fax 202–404–7920, email: NRL1004@research.nrl.navy.mil or use courier delivery to expedite response. SUMMARY: Sfmt 4703 Department of the Navy, DoD. Notice. AGENCY: ACTION: The Department of the Navy hereby gives notice of its intent to grant DBC Medical Innovations, LLC a SUMMARY: E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Pages 92791-92792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30590]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant an Exclusive License; Adaptive Phage 
Therapeutics, Inc.

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant Adaptive Phage Therapeutics, Inc. a revocable, nonassignable, 
exclusive license to practice worldwide the Government owned inventions 
described in U.S. Provisional Patent Application 62/353,517, filed 22 
June 2016 and entitled ``Bacteriophage compositions and methods of 
selection of components against specific bacteria'' as well as any 
issued patent, divisional or continuation from that and related foreign 
filings in the field of antibiotics and drug-resistant bacteria 
control.

DATES: Anyone wishing to object to the grant of this license has 
fifteen (15) days from the date of this notice to file written 
objections along with supporting evidence, if any, not later than 
January 4, 2017.

[[Page 92792]]


ADDRESSES: Written objections are to be filed with Attn: Naval Medical 
Research Center, Code 1URO/OPBD, 503 Robert Grant Avenue, Silver 
Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. T.A. Ponzio, Director, 
Partnerships & Business Development, Naval Medical Research Center, 503 
Robert Grant Ave., Silver Spring, MD 20910-7500; 
todd.a.ponzio.civ@mail.mil; telephone: 240-762-0673.

    Authority: 35 U.S.C. 207, 37 CFR part 404.


    Dated: December 14, 2016.
A.M. Nichols,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. 2016-30590 Filed 12-19-16; 8:45 am]
 BILLING CODE 3810-FF-P